Hims & Hers Health, Inc. (HIMS) Tops Q2 EPS by 2c, Offers Guidance

Hims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of $0.06, $0.02 better than the analyst estimate of $0.04. Revenue for the quarter came in at $315.6 million versus the consensus estimate of $301.6 million.

GUIDANCE:

Hims & Hers Health, Inc. sees Q3 2024 revenue of $375-380 million, versus the consensus of $323 million.

Hims & Hers Health, Inc. sees FY2024 revenue of $1.37-1.4 billion, versus the consensus of $1.24 billion.

For earnings history and earnings-related data on Hims & Hers Health, Inc. (HIMS) click here.

You May Also Be Interested In

• Explosions heard on Iran's Kharg island - MEHR
• Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James
• United States Oil Fund (USO) call put ratio 1 call to 1.2 puts as share price up 2.2%